| 000 -LEADER |
| fixed length control field |
06261cam a22004457i 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20250915115504.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
cr cnu---unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
250915t20242024enkm o u000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781786309396 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781394299096 |
| Qualifying information |
electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1394299095 |
| Qualifying information |
electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1394299079 |
| Qualifying information |
electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781394299072 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Cancelled/invalid ISBN |
9781786309396 |
| Qualifying information |
hardcover |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(OCoLC)1437723180 |
| 041 ## - LANGUAGE CODE |
| Language code of text/sound track or separate title |
eng |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
QP601 |
| Item number |
.K57 2024 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
572/.7 |
| Edition number |
23/eng/20240618 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Preferred name for the person |
Kirkiacharian, Serge, |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
| Title |
Enzymes and drugs / |
| Statement of responsibility, etc |
Serge Kirkiacharian, Julien Dumond. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc |
London, UK : |
| Name of publisher, distributor, etc |
ISTE Ltd ; |
| Place of publication, distribution, etc |
Hoboken, NJ : |
| Name of publisher, distributor, etc |
John Wiley & Sons, Inc., |
| Date of publication, distribution, etc |
2024. |
| 264 #4 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Date of publication, distribution, etc |
©2024. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
1 online resource. |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent. |
| 337 ## - MEDIA TYPE |
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia. |
| 338 ## - CARRIER TYPE |
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier. |
| 340 ## - PHYSICAL MEDIUM |
| Source |
rdacc |
| Authority record control number or standard number |
http://rdaregistry.info/termList/RDAColourContent/1003. |
| 490 1# - SERIES STATEMENT |
| Series statement |
Chemistry series. |
| 520 ## - SUMMARY, ETC. |
| Summary, etc |
Enzyme dysfunction, an essential catalyst for the smooth running of biochemical reactions and the maintenance of vital processes, is at the root of many pathologies that have paved the way for the development of numerous drugs. Aimed at pharmacists, biologists, biochemists, doctors, veterinarians, medicinal chemists and students from a wide range of disciplines, Enzymes and Drugs brings together, for the first time, extensive documentation highlighting the relationships between a large number of drugs and enzymes. The book also highlights new prospects for therapeutic discoveries offered by enzyme targeting. Numerous applications have been developed thanks to strategies for studying enzyme inhibition or activation, as well as the development of allosteric effectors, presented with their advantages and disadvantages. Various rare diseases, known as "orphan" diseases, have resulted from enzyme deficiency or absence. For their treatment, the introduction of substitute enzymes has led to major therapeutic advances. |
| 545 0# - BIOGRAPHICAL OR HISTORICAL DATA |
| Biographical or historical note |
About the Author<br/>Serge Kirkiacharian holds a doctorate in physical sciences. He is a pharmacist, professor emeritus of therapeutic chemistry, hospital practitioner and honorary head of department at Paris Hospitals. His work at the CNRS, France, and in academia focuses on the development of bioactive molecules and natural products. He has also won multiple awards for his work.<br/><br/>Julien Dumond holds a doctorate in virology and enzymology. As a team leader in pharmaceutical companies and a professor of biology and bioengineering, his research focuses on the development of enzymatic assays of pharmaceutical interest, as well as premarketing studies for drugs. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Enzymes. |
| Authority record control number |
https://id.loc.gov/authorities/subjects/sh85044229. |
| 655 #4 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Dumond, Julien, |
| Relator term |
author. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
| Uniform title |
Chemistry series (ISTE Ltd.) |
| Authority record control number |
https://id.loc.gov/authorities/names/no2024027490. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
| Uniform Resource Identifier |
https://onlinelibrary.wiley.com/doi/book/10.1002/9781394299096 |
| Link text |
Full text is available at Wiley Online Library Click here to view |
| 942 ## - ADDED ENTRY ELEMENTS |
| Source of classification or shelving scheme |
|
| Item type |
EBOOK |